BG38163A3 - Method for preparing pyrimidones - Google Patents

Method for preparing pyrimidones

Info

Publication number
BG38163A3
BG38163A3 BG057164A BG5716482A BG38163A3 BG 38163 A3 BG38163 A3 BG 38163A3 BG 057164 A BG057164 A BG 057164A BG 5716482 A BG5716482 A BG 5716482A BG 38163 A3 BG38163 A3 BG 38163A3
Authority
BG
Bulgaria
Prior art keywords
pyrimidones
preparing
proven
formulated
points
Prior art date
Application number
BG057164A
Other languages
Bulgarian (bg)
English (en)
Inventor
George Sach
Original Assignee
Smith Kline & French Laboratories Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smith Kline & French Laboratories Ltd. filed Critical Smith Kline & French Laboratories Ltd.
Publication of BG38163A3 publication Critical patent/BG38163A3/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/73—Unsubstituted amino or imino radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/61—Halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/65—One oxygen atom attached in position 3 or 5
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
  • Treating Waste Gases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Luminescent Compositions (AREA)
  • Steroid Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BG057164A 1981-06-27 1982-06-25 Method for preparing pyrimidones BG38163A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8119906 1981-06-27

Publications (1)

Publication Number Publication Date
BG38163A3 true BG38163A3 (en) 1985-10-15

Family

ID=10522859

Family Applications (1)

Application Number Title Priority Date Filing Date
BG057164A BG38163A3 (en) 1981-06-27 1982-06-25 Method for preparing pyrimidones

Country Status (27)

Country Link
US (4) US4486434A (de)
EP (2) EP0068833B1 (de)
JP (4) JPS588080A (de)
KR (1) KR880001475B1 (de)
AT (2) ATE22891T1 (de)
AU (2) AU551066B2 (de)
BG (1) BG38163A3 (de)
CS (1) CS241036B2 (de)
DD (1) DD202291A5 (de)
DE (2) DE3273782D1 (de)
DK (2) DK287082A (de)
ES (1) ES513469A0 (de)
FI (1) FI822281L (de)
GR (2) GR74926B (de)
HU (1) HU190396B (de)
IE (1) IE53348B1 (de)
IL (1) IL66125A (de)
JO (1) JO1185B1 (de)
NO (1) NO822120L (de)
NZ (1) NZ201077A (de)
PH (1) PH19680A (de)
PL (3) PL138524B1 (de)
PT (1) PT75074B (de)
SU (1) SU1232145A3 (de)
YU (1) YU138982A (de)
ZA (2) ZA824537B (de)
ZW (1) ZW13082A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN151188B (de) * 1978-02-13 1983-03-05 Smith Kline French Lab
US4808589A (en) * 1982-02-20 1989-02-28 Smith Kline & French Laboratories Limited Pyrimidone derivatives
DE3376422D1 (en) * 1982-03-25 1988-06-01 Smith Kline French Lab Process for preparing 3,5-disubstituted 2-pyridylalkyl amines
GR78463B (de) * 1982-03-25 1984-09-27 Smith Kline French Lab
PT77287B (en) * 1982-10-01 1986-02-04 Smith Kline French Lab Compound
GB8319874D0 (en) * 1983-07-23 1983-08-24 Smith Kline French Lab Compounds
CA1286297C (en) * 1985-06-13 1991-07-16 George S. Sach Pyridine derivatives
GB8601816D0 (en) * 1986-01-25 1986-02-26 Smith Kline French Lab Pyridine derivatives
GB8610867D0 (en) * 1986-05-02 1986-06-11 Smith Kline French Lab 3-hydroxypyridines
JP2679977B2 (ja) * 1986-09-19 1997-11-19 株式会社日立製作所 半導体集積回路
EP0364584A4 (en) * 1988-04-27 1990-12-05 Kievsky Nauchno-Issledovatelsky Institut Farmakologii I Toxikologii Antidote for organic phosphorus compound poisoning
US5216170A (en) * 1989-01-26 1993-06-01 Bayer Aktiengesellschaft (2-aminopropyl) pyridines useful as intermediates
KR100498005B1 (ko) * 2002-07-26 2005-07-01 주식회사 소하드 기능성 액상비료 및 그 제조방법
EP1572752B1 (de) * 2002-12-20 2014-08-13 ExxonMobil Chemical Patents Inc. Polymerisationsverfahren
US7443103B2 (en) * 2005-06-24 2008-10-28 General Electric Company High pressure lamp with lamp flicker suppression and lamp voltage control
AU2009268024A1 (en) * 2008-07-10 2010-01-14 Novartis Ag Cyclic sulfones with aminobenzyl substitution useful as BACE inhibitors

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN146736B (de) * 1975-10-02 1979-08-25 Smith Kline French Lab
US4154834A (en) * 1975-12-29 1979-05-15 Smith Kline & French Laboratories Limited Substituted isocytosines having histamine H2 -antagonist activity
US4216318A (en) * 1975-12-29 1980-08-05 Smith Kline & French Laboratories Limited Heterocyclic alkyl 4-pyrimidones
MW5076A1 (en) * 1975-12-29 1978-02-08 Smith Kline French Lab Pharmacologicalle active compounds
US4227000A (en) * 1978-04-11 1980-10-07 Smith Kline & French Laboratories Limited Intermediates in the process for making histamine antagonists
IL57416A (en) * 1978-05-30 1983-03-31 Smith Kline French Lab Nitro compounds,processes for preparing them and compositions containing them
US4255428A (en) * 1979-03-24 1981-03-10 Smith Kline & French Laboratories Limited 5-(Hydroxypyridylalkyl)-4-pyrimidones
JPS55133379A (en) * 1979-04-05 1980-10-17 Smith Kline French Lab Pyrimidone compound
EP0017680B1 (de) * 1979-04-11 1982-04-21 Smith Kline & French Laboratories Limited Pyrimidon-Derivate, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammensetzungen
JPS55145683A (en) * 1979-04-26 1980-11-13 Smith Kline French Lab Pyrimidone derivative

Also Published As

Publication number Publication date
CS241036B2 (en) 1986-03-13
AU8535182A (en) 1983-01-06
PL138524B1 (en) 1986-09-30
PT75074A (en) 1982-07-01
PL240628A1 (en) 1983-10-10
EP0068833A3 (en) 1983-03-30
ZW13082A1 (en) 1982-09-29
JPH0244812B2 (de) 1990-10-05
KR880001475B1 (ko) 1988-08-13
ZA824580B (en) 1983-05-25
SU1232145A3 (ru) 1986-05-15
IE821533L (en) 1982-12-27
ES8305755A1 (es) 1983-05-01
DE3273019D1 (en) 1986-10-09
FI822281L (fi) 1982-12-28
NZ201077A (en) 1985-09-13
NO822120L (no) 1982-12-28
JPH0345073B2 (de) 1991-07-09
PH19680A (en) 1986-06-13
GR74926B (de) 1984-07-12
ZA824537B (en) 1983-05-25
US4535163A (en) 1985-08-13
US4486434A (en) 1984-12-04
YU138982A (en) 1985-03-20
PL137627B1 (en) 1986-07-31
JPS61233670A (ja) 1986-10-17
KR840000533A (ko) 1984-02-25
CS480082A2 (en) 1985-06-13
IL66125A0 (en) 1982-09-30
US4584381A (en) 1986-04-22
PT75074B (en) 1986-02-26
JPS6328424B2 (de) 1988-06-08
EP0068834A3 (en) 1983-04-06
PL237110A1 (en) 1983-06-20
JPS588079A (ja) 1983-01-18
ES513469A0 (es) 1983-05-01
IE53348B1 (en) 1988-10-26
PL137600B1 (en) 1986-07-31
US4444772A (en) 1984-04-24
AU8535282A (en) 1983-01-06
DK286982A (da) 1982-12-28
IL66125A (en) 1986-01-31
JO1185B1 (en) 1983-11-30
EP0068833B1 (de) 1986-10-15
HU190396B (en) 1986-08-28
ATE21900T1 (de) 1986-09-15
DK287082A (da) 1982-12-28
EP0068834B1 (de) 1986-09-03
DE3273782D1 (en) 1986-11-20
EP0068834A2 (de) 1983-01-05
JPS61233616A (ja) 1986-10-17
DD202291A5 (de) 1983-09-07
JPS588080A (ja) 1983-01-18
GR74925B (de) 1984-07-12
EP0068833A2 (de) 1983-01-05
FI822281A0 (fi) 1982-06-24
ATE22891T1 (de) 1986-11-15
AU551066B2 (en) 1986-04-17

Similar Documents

Publication Publication Date Title
BG31497A3 (en) Method for obtaining of 4- amino- 5- alkyl- sulphonyl ortoanizamid
BG31645A3 (en) Method for obtaining of phenetanolamine
BG37995A3 (en) Method for preparing derivatives of 2- cyanbenzimidazol
BG34906A3 (en) Method for preparing pyrimidones
BG38333A3 (en) Method for preparing substituted phenylcarboxyoximes
BG31499A3 (en) Method for obtaining of 1- vinyl- triazol derivatives
BG37523A3 (en) Method for preparing peptides
BG32115A4 (en) Method for obtaining of midantion
BG38487A3 (en) Method for preparing peptides
BG33294A3 (en) Method for obtaining the derivatives of 4- dezacetyl- vincaledcoblactine c- 3- carboxyhydrazid
BG38334A3 (en) Method for preparing pyrolidinic derivatives
BG35328A3 (en) Method for preparing imidodisulphamidic derivatives
BG38163A3 (en) Method for preparing pyrimidones
BG35330A3 (en) Method for preparing 3- iodine- methylcephalosporines
BG31492A3 (en) Method for obtaining phenetanolamines
BG36348A3 (en) Method for preparing thienopyridinon derivatives
BG41126A3 (en) Method for preparing benzamides
BG34907A3 (en) Method for preparing benzodiazepine compounds
BG38489A3 (en) Method for preparing oxazophosphorine- 6, 4- thiolcalsulphonic acids and their neutral salts
BG37525A3 (en) Method for preparing n- substituted flavon- 8- carbonamides
BG37992A3 (en) Method for preparing derivatives of benzamide
BG38638A3 (en) Method for preparing arylcyclobutyl- aminoderivatives
BG36630A3 (en) Method for preparing substituted diphenylic ethers
BG35897A3 (en) Method for preparing 5- (dihydroxy- phenoxy)- 1h- tetrazoles
BG36495A3 (en) Method for preparing 4- quinolic derivatives